Spruce Biosciences is preparing a BLA submission in Q4, with FDA feedback suggesting acceptance of CSF HS-NRE as a surrogate ...
NeuroTherapia, Inc., a clinical-stage company focused on developing oral therapies for neurodegenerative diseases, will be presenting data from its recently completed Phase 2a clinical trial in ...
Florence specialists use spinal fluid drainage, MOCA and walking tests to gauge which normal pressure hydrocephalus patients ...
Cognitive decline in very old adults has been considered for decades to be an almost inevitable consequence of aging. In clinical practice, this has contributed to many memory problems in patients ...
Over a six-week training camp, one writer immerses himself into the fight game's most perilous obsession — all to discover how brutal the culture of extreme weight-cutting really is.
Discusses Preliminary Phase II Results for SNT-4728 in Isolated REM Sleep Behavior Disorder July 5, 2026 11:30 PM ...
Cognitive decline in very old adults has been considered for decades to be an almost inevitable consequence of aging. In clinical practice, this has ...
FDA confirmed no additional studies required, existing longer-term data from the CAMPSIITE® study will be reviewed on an expedited basis for approval via the accelerated ...
Cognitive decline in very old adults has been considered for decades to be an almost inevitable consequence of aging.
Researchers say their sensor can monitor levels of the neurotransmitter in real time, bringing at-home health management ...
Morning Overview on MSN
A brain protein that helps neurons talk may be helping Alzheimer’s spread, Utah scientists found
A protein that neurons rely on to share genetic messages with each other also packages and spreads toxic tau, the misfolded ...
Introduction Bronchopulmonary dysplasia (BPD) remains a major complication among extremely low gestational age (ELGA) infants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results